1. Revisiting FDA Approval of Aducanumab;Alexander;New England Journal of Medicine,2021
2. Cicchiello
Aimee
, and GustaffsonLovisa. 2021. “Brand-Name Drug Prices: The Key Driver of High Pharmaceutical Spending in the US.” Commonwealth Fund, November17. https://www.commonwealthfund.org/publications/2021/nov/brand-name-drug-prices-key-driver-high-pharmaceutical-spending-in-us.
3. How They Did It—The Inside Account of Health Care Reform's Triumph;Cohn;New Republic,2010
4. Cubanski
Juliette
, NeumanTricia, FreedMeredith, and DamicoAnthony. 2022. “How Will the Prescription Drug Provisions in the Inflation Reduction Act Affect Medicare Beneficiaries?” Kaiser Family Foundation, August18. https://www.kff.org/medicare/issue-brief/how-will-the-prescription-drug-provisions-in-the-inflation-reduction-act-affect-medicare-beneficiaries/.
5. Diamond
Dan
, and GoldsteinAmy. 2021. “A Bitter Bill: Biden Suffers Familiar Defeat on Prescription Drug Prices.” Washington Post, October29. https://www.washingtonpost.com/health/2021/10/29/biden-medicare-drug-negotiation/.